Sinovac Biotech CoronaVac COVID-19 vaccine candidate succeeds in phase 1/2 trial
Sinovac Biotech said that the phase 1/2 clinical trial for its coronavirus vaccine candidate CoronaVac has delivered positive…
Medtronic secures $337m from Blackstone to develop diabetes technologies
Irish medical device company Medtronic has secured a $337 million product investment from Blackstone Life Sciences for advancing new,…
Novo Nordisk to acquire cardio-renal disease company Corvidia Therapeutics
Novo Nordisk acquisition of Corvidia : Danish pharma company Novo Nordisk has agreed to acquire Corvidia Therapeutics from…
Regeneron Pharmaceuticals begins COVID-19 clinical trials of REGN-COV2
US biotech company Regeneron Pharmaceuticals has started the first clinical trial of its investigational dual antibody cocktail REGN-COV2…
Leap Therapeutics gets FDA orphan status for DKN-01 for gastric and gastroesophageal junction cancer
US immuno-oncology company Leap Therapeutics has been granted orphan drug designation for DKN-01 from the US Food and…
US biotech company Viela Bio bags Uplizna FDA approval for NMOSD
Uplizna FDA approval : US biotech company Viela Bio has secured approval from the US Food and Drug…
Mylan, Biocon get FDA approval for Semglee in type 1 and 2 diabetes
Mylan and Biocon have secured approval from the US Food and Drug Administration (FDA) for Semglee (insulin glargine…
Nestlé to acquire majority stake in US collagen brand Vital Proteins
NestlĂ© Health Science (NHSc) has agreed to acquire a majority stake in Vital Proteins, a US collagen brand…
Victory Nutrition launches PerformLyte electrolyte, phytonutrient formula
Victory Nutrition International has launched PerformLyte, new Prodosomed electrolyte and phytonutrient formula, which is said to promote immunity,…
RapidAI acquires aneurysm management platform developer EndoVantage
RapidAI, an AI-based medical imaging company, has acquired EndoVantage, the developer of the Find, Track and Treat cerebral…